Workforce Development
The addiction-treatment workforce needs urgent expansion to meet projected demand, with persistent recruitment and retention challenges. The session covers clinician recruitment and retention strategies, peer workforce growth and integration, telehealth-enabled care delivery expanding access in rural and underserved regions, workforce equity including underrepresented minorities in addiction-medicine training, pipeline programmes from undergraduate to clinical practice, and burnout-prevention strategies. Discussion addresses loan-repayment programmes (NHSC and STAR LRP), the addiction-medicine vs addiction-psychiatry workforce data, advanced-practice nursing scope of practice, the international addiction-medicine workforce shortage, and emerging models for community-based addiction-counsellor training.
- Clinician recruitment and retention
- Peer workforce growth
- Telehealth workforce expansion
- Workforce equity
- NHSC and STAR LRP
- Pipeline programmes
- Burnout prevention
- Advanced practice nursing scope
Explore the full WCAM 2027 program
- 01Opioid Use Disorder
- 02Alcohol Use Disorder
- 03Stimulants & Polysubstance Use
- 04Behavioral Addictions
- 05Harm Reduction
- 06Medication-Assisted Treatment
- 07Recovery Support Services
- 08Prevention & Early Intervention
- 09Neuroscience of Addiction
- 10Trauma & PTSD-Related Use
- 11Adolescent Addiction
- 12Pregnancy & Addiction
- 13Co-occurring Mental Illness
- 14Tobacco & Nicotine Cessation
- 15Cannabis Use Disorder
- 16Psychedelic-Assisted Therapy
- 17Digital Therapeutics in Addiction
- 18Addiction Policy & Public Health
- 19Methadone & Buprenorphine Programs
- 20Naloxone & Overdose Prevention
- 21Recovery Housing
- 22Peer Support Specialists
- 23Addiction Medicine Training
- 24Stigma & Communication
- 25Drug Policy Reform
- 26International Drug Trends
- 27Older Adults & Addiction
- 28Veterans & Addiction
- 29Criminal Justice & Treatment
- 30Family Therapy
- 31Spirituality & Recovery
- 32Genetics of Addiction
- 33Polysubstance Use Trends
- 34Emerging Drugs of Abuse